Literature DB >> 8246018

Pharmacologic-based dosing of carboplatin: a better method.

K R Hande.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8246018     DOI： 10.1200/JCO.1993.11.12.2295

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Analysis of thrombocytopenia due to carboplatin combined with etoposide in elderly patients with lung cancer.

Authors:  K Shibata; Y Nakatsumi; K Kasahara; T Bando; M Fujimura; T Matsuda
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 2.  Clinical pharmacokinetics and dose optimisation of carboplatin.

Authors:  S B Duffull; B A Robinson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

3.  Carboplatin-associated ototoxicity in children with retinoblastoma.

Authors:  Ibrahim Qaddoumi; Johnnie K Bass; Jianrong Wu; Catherine A Billups; Amy W Wozniak; Thomas E Merchant; Barrett G Haik; Matthew W Wilson; Carlos Rodriguez-Galindo
Journal:  J Clin Oncol       Date:  2012-02-27       Impact factor: 44.544

4.  A pharmacologically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancer.

Authors:  E Chatelut; C Chevreau; V Brunner; M Martinez; G Houin; R Bugat; P Canal
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

5.  Quality of pharmacokinetic research in oncology.

Authors:  J Siderov; J E Brien; D J Morgan; J Zalcberg; W Cosolo
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.